Literature DB >> 6420704

Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence.

B Bloch, N Ling, R Benoit, W B Wehrenberg, R Guillemin.   

Abstract

A potent and specific growth hormone-releasing factor (GRF) was recently isolated and characterized from a human islet cell tumour of the pancreas that caused acromegaly. Antibodies raised against the synthetic replicate of this peptide have allowed the immunohistochemical identification of GRF-producing neurones within the primate central nervous system. Such neurones are found mainly in the arcuate nucleus in human and monkey hypothalamus, suggesting that this nucleus is a primary source of GRF. We have further investigated this hypothesis by studying the anatomical organization of GRF neurones in rat hypothalamus, using an antibody raised against the recently characterized rat hypothalamic GRF in normal animals and in animals neonatally treated with monosodium glutamate (MSG), a treatment which results in the selective destruction of arcuate nucleus neurones. We present here the results which show that GRF-producing neurones are located mainly in the arcuate nucleus of rats. MSG treatment results in the complete loss of GRF-immunoreactive cell bodies within this nucleus and provokes a selective disappearance of GRF-immunoreactive fibres in the median eminence. These results show that the arcuate nucleus is the origin of the GRF-containing fibres that project to the median eminence and establish the MSG-treated rat as an in vivo model for studying growth hormone secretion in the absence of neurohumoral GRF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420704     DOI: 10.1038/307272a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  9 in total

1.  Synaptic communication between somatostatinergic axons and growth hormone-releasing factor (GRF) synthesizing neurons in the arcuate nucleus of the rat.

Authors:  Z Liposits; I Merchenthaler; W K Paull; B Flerkó
Journal:  Histochemistry       Date:  1988

Review 2.  Role of excitatory amino acids in the control of growth hormone secretion.

Authors:  Enrique Aguilar; Manuel Tena-Sempere; Leonor Pinilla
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

3.  Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions.

Authors:  B Meister; S Ceccatelli; T Hökfelt; N E Andén; M Andén; E Theodorsson
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

4.  Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry.

Authors:  B Bloch; T Popovici; M J Levin; D Tuil; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Ontogenetic appearance of immunoreactive GRF-containing neurons in the rat hypothalamus.

Authors:  S Daikoku; H Kawano; M Noguchi; M Tokuzen; K Chihara; H Saito; T Shibasaki
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

6.  Neonatal exposure to monosodium glutamate induces morphological alterations in suprachiasmatic nucleus of adult rat.

Authors:  Julio César Rojas-Castañeda; Rosa María Vigueras-Villaseñor; Margarita Chávez-Saldaña; Patricia Rojas; Oscar Gutiérrez-Pérez; Carolina Rojas; Marcela Arteaga-Silva
Journal:  Int J Exp Pathol       Date:  2016-01-21       Impact factor: 1.925

7.  Modulation of cholecystokinin concentrations in the rat hippocampus by chelation of heavy metals.

Authors:  K Stengaard-Pedersen; L I Larsson; K Fredens; J F Rehfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

8.  Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency?

Authors:  A E Stevenson; B A J Evans; E F Gevers; C Elford; R W J McLeod; M J Perry; M M El-Kasti; K T Coschigano; J J Kopchick; S L Evans; T Wells
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-11       Impact factor: 4.310

9.  Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease.

Authors:  Erik Karl Håkan Clemensson; Laura Emily Clemensson; Benedikt Fabry; Stefanie Flunkert; Olaf Riess; Robert Wronski; Huu Phuc Nguyen
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.